Faina Nakhlis

1.2k total citations
74 papers, 773 citations indexed

About

Faina Nakhlis is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Faina Nakhlis has authored 74 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cancer Research, 43 papers in Oncology and 34 papers in Pathology and Forensic Medicine. Recurrent topics in Faina Nakhlis's work include Breast Cancer Treatment Studies (50 papers), Breast Lesions and Carcinomas (32 papers) and Breast Implant and Reconstruction (16 papers). Faina Nakhlis is often cited by papers focused on Breast Cancer Treatment Studies (50 papers), Breast Lesions and Carcinomas (32 papers) and Breast Implant and Reconstruction (16 papers). Faina Nakhlis collaborates with scholars based in United States, Canada and Netherlands. Faina Nakhlis's co-authors include Mehra Golshan, Tari A. King, Jennifer R. Bellon, Beth Overmoyer, Susan E. Clare, John C. Panetta, Eren D. Yeh, Heather A. Jacene, Susan C. Lester and Monica Morrow and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Faina Nakhlis

69 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faina Nakhlis United States 18 506 407 298 207 128 74 773
Ines Gruber Germany 18 349 0.7× 299 0.7× 265 0.9× 93 0.4× 70 0.5× 39 764
J. A. Andersen Denmark 5 472 0.9× 285 0.7× 300 1.0× 150 0.7× 41 0.3× 9 651
U Dyreborg Denmark 12 263 0.5× 272 0.7× 270 0.9× 106 0.5× 146 1.1× 31 621
Dieter Lampe Germany 14 550 1.1× 425 1.0× 412 1.4× 97 0.5× 51 0.4× 32 1.1k
Shoshu Mitsuyama Japan 16 293 0.6× 216 0.5× 337 1.1× 143 0.7× 92 0.7× 82 737
Mary Morrogh United States 14 416 0.8× 406 1.0× 276 0.9× 115 0.6× 185 1.4× 20 745
Kotaro Iijima Japan 18 487 1.0× 276 0.7× 503 1.7× 153 0.7× 91 0.7× 59 873
Gaston Demonty Switzerland 15 287 0.6× 251 0.6× 458 1.5× 197 1.0× 68 0.5× 41 715
Amy Cyr United States 16 420 0.8× 281 0.7× 178 0.6× 246 1.2× 44 0.3× 46 607
Shu Wan Kau United States 12 633 1.3× 418 1.0× 453 1.5× 155 0.7× 129 1.0× 14 843

Countries citing papers authored by Faina Nakhlis

Since Specialization
Citations

This map shows the geographic impact of Faina Nakhlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faina Nakhlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faina Nakhlis more than expected).

Fields of papers citing papers by Faina Nakhlis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faina Nakhlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faina Nakhlis. The network helps show where Faina Nakhlis may publish in the future.

Co-authorship network of co-authors of Faina Nakhlis

This figure shows the co-authorship network connecting the top 25 collaborators of Faina Nakhlis. A scholar is included among the top collaborators of Faina Nakhlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faina Nakhlis. Faina Nakhlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Leone, José Pablo, Julieta Leone, Faina Nakhlis, et al.. (2024). Survival outcomes and treatment patterns by tumor subtype (TS) in stage III inflammatory and non-inflammatory breast cancer (BC).. Journal of Clinical Oncology. 42(16_suppl). 607–607. 1 indexed citations
3.
Tarantino, Paolo, Antonio Giordano, Faina Nakhlis, et al.. (2024). Abstract PO3-20-06: TRUDI: A phase II study of neoadjuvant TRastuzumab derUxtecan and Durvalumab for stage III HER2-expressing Inflammatory breast cancer. Cancer Research. 84(9_Supplement). PO3–20. 2 indexed citations
4.
Hirko, Kelly A., Faina Nakhlis, Jennifer R. Bellon, et al.. (2024). Abstract PO1-09-10: County-level Social Vulnerability and Survival among Women with Inflammatory Breast Cancer. Cancer Research. 84(9_Supplement). PO1–9. 1 indexed citations
5.
Park, Ko Un, Stuart R. Lipsitz, Laura S. Dominici, et al.. (2024). Generative artificial intelligence as a source of breast cancer information for patients: Proceed with caution. Cancer. 131(1). e35521–e35521. 4 indexed citations
6.
Weiss, Anna, et al.. (2022). Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 195(2). 181–189. 9 indexed citations
7.
Tarantino, Paolo, Samuel M. Niman, Nolan Priedigkeit, et al.. (2022). HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. European Journal of Cancer. 174. 277–286. 16 indexed citations
8.
Yeh, Eren D., Faina Nakhlis, Camden Bay, et al.. (2021). MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast Cancer. Academic Radiology. 29(5). 637–647.
9.
Fayanju, Oluwadamilola M., Yi Ren, Rachel A. Greenup, et al.. (2020). Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients. Breast Cancer Research and Treatment. 180(1). 207–217. 21 indexed citations
10.
Jacene, Heather A., Pamela J. DiPiro, Jennifer R. Bellon, et al.. (2020). Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. Breast Cancer Research and Treatment. 181(2). 383–390. 19 indexed citations
11.
Harrison, Beth, Faina Nakhlis, Deborah Dillon, et al.. (2020). Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Modern Pathology. 33(7). 1287–1297. 21 indexed citations
12.
Nakhlis, Faina. (2020). Oncoplastic Breast Surgery – Pros and Cons for the Breast Surgical Oncologist. SHILAP Revista de lepidopterología. 97–99. 1 indexed citations
13.
Minami, Christina A., Olga Kantor, Anna Weiss, et al.. (2020). Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer. Journal of the American College of Surgeons. 231(4). 434–447e2. 21 indexed citations
14.
Laws, Alison, Melissa E. Hughes, Jiani Hu, et al.. (2019). Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 26(12). 3846–3855. 20 indexed citations
15.
Keene, K.S., Tari A. King, E. Shelley Hwang, et al.. (2018). Molecular determinants of post-mastectomy breast cancer recurrence. npj Breast Cancer. 4(1). 34–34. 9 indexed citations
16.
Nakhlis, Faina, Beth Harrison, Catherine S. Giess, et al.. (2018). Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Annals of Surgical Oncology. 26(1). 55–61. 29 indexed citations
17.
18.
Warren, Laura, Hao Guo, Meredith M. Regan, et al.. (2015). Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management. Annals of Surgical Oncology. 22(8). 2483–2491. 26 indexed citations
19.
Nakhlis, Faina & Mehra Golshan. (2012). Bevacizumab: where do we go from here in breast cancer?. Translational Cancer Research. 1(1). 55–56. 3 indexed citations
20.
Nakhlis, Faina, Nanjiang Hou, Seema A. Khan, et al.. (2005). Tamoxifen Use in Patients with Ductal Carcinoma In Situ and T1a/b N0 Invasive Carcinoma. Journal of the American College of Surgeons. 201(5). 688–694. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ines Gruber Breakdown of academic impact, for papers by J. A. Andersen Breakdown of academic impact, for papers by U Dyreborg Breakdown of academic impact, for papers by Dieter Lampe Breakdown of academic impact, for papers by Shoshu Mitsuyama Breakdown of academic impact, for papers by Mary Morrogh Breakdown of academic impact, for papers by Kotaro Iijima Breakdown of academic impact, for papers by Gaston Demonty Breakdown of academic impact, for papers by Amy Cyr Breakdown of academic impact, for papers by Shu Wan Kau
Rankless by CCL
2026